ALB and fibrosis: At 4 and 8 weeks after injection, serum levels of liver enzymes were analyzed and found that ALT and AST (except Week 8) activities, but not TBIL, DBIL, and Alb (except for Week 4), were significantly elevated in the fibrosis model group (Figure S4B).